ResearchDx and Menarini Silicon Biosystems Launch DEPArray HER2 for Breast and GEA Cancers

Irvine, CA—October 2, 2017—ResearchDx, the leading biopharma companion diagnostics provider and Menarini Silicon Biosystems, worldwide manufacturer of image-based cell sorting products and services, jointly announce the launch of DEPArray HER2. The fluorescence in situ hybridization (FISH)-based assay has been validated as a clinical research laboratory developed test (LDT) and is performed by PacificDx, a CAP/CLIA certified and […]

Read More

ResearchDx, Inc. and PacificDx Expand Existing Clinical Laboratory and Office Space to Accommodate New Research Partners and Assays

Leading contract diagnostics organization has completed construction of a 12,000 square foot addition to their office in Irvine, CA creating a 30,000 square foot headquarters in Irvine, CA. Irvine, CA—February 1, 2017—ResearchDx, Inc. announced today that construction is completed on a major addition to their Orange County headquarters. The company’s building at 5 Mason in […]

Read More

ResearchDx/PacificDx to Present High-Resolution HER2 Testing Data at the San Antonio Breast Cancer Symposium

Leading contract diagnostics organization demonstrates the value of DNA-based testing for identifying the HER2-Low genomic subtype in high-risk HER2 equivocal breast cancer Irvine, CA—December 1, 2016—ResearchDx/PacificDx announced today that it will share findings demonstrating the value of DNA microarray comparative genomic hybridization (array CGH) for HER2 genomic subtyping in breast cancer patients at this year’s San […]

Read More

ResearchDx And BioSmartSA Announce New Consulting Practice in Saudi Arabia

Irvine, California and Riyadh, Saudi Arabia, May 17, 2016 — ResearchDx, the premier Contract Diagnostics Organization (CDO) for the biopharmaceutical industry, and BioSmartSA, a healthcare consultancy based in Saudi Arabia, have formed a partnership to bring their expertise in navigating the design and management of diagnostic services to healthcare providers in the Kingdom of Saudi Arabia […]

Read More

ResearchDx Appointment of New Chief Medical Officer to Meet NIH Push for Precision Medicine in Expediting “Bench to Bedside” Strategies for Disease Treatment

Irvine, CA—December 7, 2015—Internationally recognized as the “Contract Diagnostics Organization,” ResearchDx specializes in the development of companion and in vitro diagnostics for the pharmaceutical, biotechnology, research, and diagnostic industries. To meet the demand for leveraging new technology and increase the speed at which new treatments reach patients, life sciences firm ResearchDx has appointed Shelly Gunn […]

Read More

Irvine’s ResearchDx Signs Agreement with Micron, Inc. of Tokyo

Irvine, CA—February 14, 2015—ResearchDx, Inc. of Irvine, California and Micron Inc. of Tokyo, Japan have entered into an agreement for international collaborative clinical trials. The in vitro diagnostic development processes, laboratory and clinical services of ResearchDx will partner well with Micron’s imaging technologies. Through the collaboration, companies in the U.S., Canada, the European Union, Central […]

Read More